510(k) Report

FDA product code · Cardiovascular

Sensor, Pressure, Aneurysm, Implantable

NQHClass II21 CFR 870.2855510(k) required5 decisions since 20050 recalls

5 FDA decisions since 2005. No recall names this code.

This device is intended to measure the pressure in the aneurysm sac during and after an endovascular procedure.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, cardiovascular panel

Twenty years of NQH at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · NQH

1in 2008

2007: 22008: 1
2007high 2 (2007) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NQH

Too few NQH 510(k)s in any year since 2007 to give a median.

Recalls per year · NQH

No recall names NQH since 2007.

Adverse event reports per year · NQH

2in 2009

2007: 172008: 82009: 2
2007high 17 (2007) · low 0 (2010)2025

MAUDE reports naming product code NQH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—017
20081—08
20090—02
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—
FIG. 1 — NQH by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in NQH? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report